Mixing Cells for Vascularized Kidney Regeneration.

Area of Science:

• Biomedical engineering
• Regenerative medicine
• Nephrology

Background:

• Chronic kidney disease (CKD) prevalence is rising globally, necessitating advanced regenerative therapies.
• Current kidney regenerative medicine strategies focus on replacing lost tissue and rejuvenating remaining kidney structures.
• Cellular therapies using kidney tissue-forming cells (KTFCs) are being explored, but face challenges in harsh diseased environments.

Purpose of the Study:

• To review diverse sources of KTFCs and vessel-forming cells (VFCs) for kidney regeneration.
• To highlight advances in generating vascularized kidney tissue through cell transplantation.
• To emphasize the importance of co-transplanting KTFCs with VFCs for enhanced cell engraftment and potency.

Main Methods:

• Review of scientific literature on KTFCs and VFCs from various cell sources (fetal, adult, pluripotent stem cells).
• Analysis of synergistic effects between KTFCs and VFCs (endothelial cells and mesenchymal stem cells) in forming blood vessels.
• Examination of recent progress in cell transplantation for kidney regeneration.

Main Results:

• Vessel-forming cells (VFCs), including endothelial cells (ECs) and mesenchymal stem cells (MSCs), are crucial for vascularizing transplanted kidney tissue.
• Co-transplantation of KTFCs with VFCs promotes the formation of stable blood vessels, essential for self-organizing KTFCs into functional renovascular units.
• Successful vascularization enhances the engraftment and potency of transplanted cells in the diseased kidney environment.

Conclusions:

• Combining KTFCs with VFCs is a promising strategy for kidney regenerative medicine.
• Vascularization is key to successful kidney tissue regeneration and restoration of kidney function.
• Further research into cell transplantation holds potential for treating millions of kidney patients worldwide.